Open Access Highly Accessed Research article

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy

Alessandra Fabi*, Michelangelo Russillo, Gianluigi Ferretti, Giulio Metro, Cecilia Nisticò, Paola Papaldo, Ferdinando De Vita, Giuliana D’Auria, Antonello Vidiri, Diana Giannarelli and Francesco Cognetti

BMC Cancer 2012, 12:482  doi:10.1186/1471-2407-12-482

Article Metrics

Total accesses

Article metric FAQ


  • Last 30 days: 43 accesses
  • Last 365 days: 596 accesses
  • All time: 2482 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information